In pMMR/MSS colon cancer, neoadjuvant BOT+BAL met the trial’s primary endpoint with a 36% major pathologic response rate, including 29% pathologic complete response, within an overall 71% pathologic ...
UNICORN Challenges Immunotherapy Resistance in MSS Colon Cancer / Agenus, Balstilimab, botensilimab, cancer, Colon cancer, ...
For patients with colorectal liver metastases (CRLM), laparoscopic liver resection (LLR) is associated with lower ...
WBAL-TV on MSN
Intestinal ultrasounds can ease endoscopy need
Using an intestinal ultrasound may help patients avoid having to undergo invasive procedures, like colonoscopies, as often.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results